Cited 50 times in
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.